At NINGBO INNO PHARMCHEM CO.,LTD., we focus on delivering high-quality chemical compounds that serve critical functions across scientific and medical fields. Pralidoxime Chloride, identified by its CAS number 51-15-0, is a prime example of such a compound, playing a vital role in toxicology and acting as a key pharmaceutical intermediate.

The synthesis and understanding of Pralidoxime Chloride's chemical properties are essential for its effective application. As an oxime derivative, its molecular structure is specifically designed to interact with and neutralize the effects of organophosphates. The core of its therapeutic action, the pralidoxime chloride mechanism of action, involves the reactivation of acetylcholinesterase. This enzyme is crucial for nerve signal transmission, and its inhibition by organophosphates leads to severe health consequences, including those seen in organophosphate poisoning.

In toxicological studies, Pralidoxime Chloride serves as a benchmark compound for understanding enzyme reactivation. Its ability to reactivate acetylcholinesterase organophosphate exposure makes it invaluable for research aimed at developing new antidotes or understanding the mechanisms of neurotoxic agents. The compound's consistent quality, supplied by NINGBO INNO PHARMCHEM CO.,LTD., ensures reliable results in laboratory settings.

Beyond research, Pralidoxime Chloride is also recognized for its utility as a veterinary raw material. Its applications highlight its versatility in addressing poisoning incidents in animals. The targeted veterinary use of pralidoxime chloride demonstrates its broad impact in safeguarding health, whether in a research laboratory or a veterinary clinic. Its journey from synthesis to application underscores its importance in modern chemical and medical science.